"You're thinking gouda when it's clearly brie time, baby."
Brenum, why are you assuming that this company is incapable of handling the influx of these new drugs. K is completely out of our hands and steadily progressing through its cohorts. B seems to be being shopped at the partnership conference. P is on "hold" although that does not mean that nothing is being done with it currently.
The Polyheist was not that long ago and here we are announcing positive initial results from a couple of those aquired drugs. That seems pretty positive to me.
As far as current SP, I am in agreement that RESULTS are what will push this higher, but calling this PR "fluff" is unfair. Would you rather the company never said anything?
Part of the problem is our demand for instant gratification, via higher SP, but that is just not how the markets work.
MT